Rosiglitazone-d3 Catalog No.:M24882-C resulting in the inhibition of

resulting in the inhibition of tumor angiogenesis

H2O4S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14

DNA modification by H2A occurs in the cell nucleus

Genistein 7

Epertinib shows potent antitumor activity

Rosiglitazone-d3 Catalog No.:M24882-C resulting in the inhibition ofRosiglitazone d3 (BRL 49653 d3) is the deuterium labeled Rosiglitazone. Rosiglitazone (BRL 49653) is a selective, orally active PPAR agonist with EC50s of 30 nM, 100 nM and 60 nM for PPAR1, PPAR2, and PPAR, respectively. Rosiglitazone binds to PPAR with a Kd of approximately 40 nM. Rosiglitazone is also an activator of TRPC5 (EC50=~30 M) and an inhibitor of TRPM3. Product information CAS Number: 1132641 22 5 Molecular Weight: 360. 45 Formula: